{
  "id": 15883045,
  "title": "STAT+: Roivant says closely watched immune drug succeeded in new eye disease",
  "url": "https://urgent.news/2026/10/21/stat-roivant-says-closely-watched-immune-drug-succeeded-in-new-eye",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-21T12:05:54.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/10/21/roivant-immune-drug-lisraya-noninfectious-uveitis-trial-results/"
  },
  "original_language": "en",
  "account": null,
  "summary": "An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}